Galindo E, Mendez M, Calvo S, Gonzalez-Garcia C, Ceña V, Hubert P, Bader M F, Aunis D
Unité Institut National de la Santé et de la Recherche Médicale, U-338 Biologie de la Communication Cellulaire, Strasbourg, France.
J Biol Chem. 1992 Jan 5;267(1):407-12.
One of the functions of chromogranin A (CGA), the major soluble component of secretory granules in both adrenal medullary chromaffin cells and many other endocrine cell types appears to be that of a prohormone. CGA is the precursor of several peptides including pancreastatin, a 49-residue peptide, and a 20-residue peptide, chromostatin, which have been identified as biologically active peptides. Chromostatin produces a dose-dependent inhibition (ID50 of 5 nM) of the secretagogue-evoked catecholamine secretion from chromaffin cells. Here we report that chromostatin potently inhibits L-type calcium currents recorded with the nystatin-perforated patch technique in cultured chromaffin cells. This inhibitory effect of chromostatin on calcium currents was not observed in experiments using the classical patch-clamp whole-cell approach which induces the leakage of cytoplasmic components. Using 125I-chromostatin, we show that chromostatin exhibits a fully reversible and saturable binding to the plasma membrane of cultured chromaffin cells. Analysis of binding experiments at equilibrium indicates the existence of one class of binding sites with a Bmax of 2.7 pmol/mg of chromaffin cell proteins and an apparent Kd of 6.5 nM. This high affinity is in good correlation with the half-maximal concentration (ID50 5 nM) of chromostatin inhibiting catecholamine secretion from chromaffin cells. Specificity of the chromostatin binding was further assessed by displacement experiments with unlabeled CGA-related or -unrelated peptides. We found an excellent quantitative correlation between the affinities of the various peptides determined by binding assays and their functional potency tested on catecholamine secretion: bovine chromostatin greater than human chromostatin greater than CGA much greater than rat chromostatin, pancreastatin, CAP-14, substance P, and Leu-enkephalin. Cross-linking experiments reveal that chromostatin associates specifically with an 80-kDa plasma membrane protein. These results together with the patch-clamp experiments support the idea that chromaffin cells possess specific chromostatin receptors and that activation of such receptors leads to the inhibition of L-type voltage-sensitive calcium channels through an intracellular second messenger pathway.
嗜铬粒蛋白A(CGA)是肾上腺髓质嗜铬细胞和许多其他内分泌细胞类型分泌颗粒的主要可溶性成分,其功能之一似乎是作为一种激素原。CGA是几种肽的前体,包括胰抑制素(一种49个氨基酸残基的肽)和一种20个氨基酸残基的肽——嗜铬粒抑制素,它们已被鉴定为生物活性肽。嗜铬粒抑制素对促分泌剂诱发的嗜铬细胞儿茶酚胺分泌产生剂量依赖性抑制(半数抑制浓度ID50为5 nM)。在此我们报告,嗜铬粒抑制素能有效抑制用制霉菌素穿孔膜片钳技术在培养的嗜铬细胞中记录的L型钙电流。在使用经典膜片钳全细胞方法(该方法会导致细胞质成分泄漏)的实验中未观察到嗜铬粒抑制素对钙电流的这种抑制作用。使用125I-嗜铬粒抑制素,我们表明嗜铬粒抑制素与培养的嗜铬细胞质膜表现出完全可逆且可饱和的结合。平衡结合实验分析表明存在一类结合位点,其最大结合容量Bmax为2.7 pmol/mg嗜铬细胞蛋白,表观解离常数Kd为6.5 nM。这种高亲和力与嗜铬粒抑制素抑制嗜铬细胞儿茶酚胺分泌的半数最大浓度(ID50为5 nM)高度相关。通过用未标记的与CGA相关或不相关的肽进行置换实验进一步评估了嗜铬粒抑制素结合的特异性。我们发现结合测定确定的各种肽的亲和力与其对儿茶酚胺分泌测试的功能效力之间存在极好的定量相关性:牛嗜铬粒抑制素>人嗜铬粒抑制素>CGA>>大鼠嗜铬粒抑制素、胰抑制素、CAP-14、P物质和亮氨酸脑啡肽。交联实验表明嗜铬粒抑制素与一种80 kDa的质膜蛋白特异性结合。这些结果与膜片钳实验一起支持了这样的观点,即嗜铬细胞具有特异性的嗜铬粒抑制素受体,并且此类受体的激活通过细胞内第二信使途径导致L型电压敏感性钙通道的抑制。